Does Finasteride Actually Work? What 25 Years of Clinical Data Shows

Finasteride has more clinical evidence behind it than almost any other hair loss treatment in history. Here's what the data actually says.

Finasteride (brand name Propecia) was FDA-approved for male pattern hair loss in 1997. That gives us over 25 years of clinical data, post-marketing surveillance, and real-world evidence — a dataset that very few treatments in any medical category can match. Despite this, online forums are full of conflicting anecdotes that make the drug seem controversial. The clinical evidence is not.

The Landmark Trials

The Original FDA Approval Studies

Merck's pivotal trials enrolled over 1,800 men with mild to moderate hair loss and followed them for 2 years. The results were decisive: 83% of men on finasteride maintained their hair count versus 72% of placebo patients who continued losing hair. More impressively, 66% of finasteride users experienced measurable regrowth — meaning new hair, not just slower loss.

The 5-Year Extension Study (Kaufman 1998)

When the original trial participants were followed for 5 years, the results held. Finasteride users continued to maintain hair count above baseline while placebo patients continued to lose ground. The gap between the two groups widened over time — a critical finding because it shows finasteride's benefit compounds rather than fading.

The 10-Year Japanese Study (Yanagisawa 2019)

One of the longest finasteride studies ever conducted followed 532 Japanese men for 10 years. At the 10-year mark, 99.1% of patients reported maintained or improved hair status. While this was an observational study (not placebo-controlled), the retention rate is remarkable and speaks to long-term viability.

What About Side Effects?

The most commonly discussed concern is sexual side effects. Here's what the clinical trial data actually shows:

The differences between drug and placebo groups are small — roughly 0.5–1 percentage points. The majority of men who experience side effects find they resolve after discontinuation. A subset of men report persistent effects after stopping the drug, a phenomenon termed "post-finasteride syndrome." This remains under active investigation, and while the FDA added label warnings, the clinical evidence for a persistent, drug-caused syndrome is still debated in the medical literature.

Does It Work Better for Some Men?

Yes. Several factors predict better response:

• Younger age at start — Men under 40 respond better than those over 50
• Earlier Norwood stage — NW2-3 responds much better than NW5+
• Crown vs. hairline — Crown hair responds more robustly than frontal hairline
• Shorter duration of loss — Recently thinned areas regrow more readily

This is why every dermatologist will tell you: start early. The drug is most effective when hair follicles are still viable but under attack — not after they've been dormant for years.

The Bottom Line

Finasteride has one of the strongest evidence bases of any medication in dermatology. It works for the vast majority of men, it's been tested for over 25 years, and it costs less than a daily coffee. The men who get the best results are those who start early, stay consistent, and give it at least 12 months before judging outcomes.

If you've been researching and going back and forth, the data is clear. Talk to a provider.

Paid link

Paid link